SUN Pharmaceutical Industries Limited — Tramadol Exporter Profile
Indian Pharmaceutical Exporter · #7 for Tramadol · $5.1M export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #7 Indian exporter of Tramadol with $5.1M in export value and 102 verified shipments. SUN Pharmaceutical Industries Limited holds a 2.6% market share in Tramadol exports across 4 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited — Tramadol Export Profile: Buyers & Destinations
Where Does SUN Pharmaceutical Industries Limited Export Tramadol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.1M | 54 | 51.7% |
| CANADA | $1.0M | 25 | 26.2% |
| SOUTH AFRICA | $877.3K | 25 | 22.0% |
| HUNGARY | $0 | 1 | 0.0% |
SUN Pharmaceutical Industries Limited exports Tramadol to 4 countries. The largest destination is UNITED STATES accounting for 51.7% of SUN Pharmaceutical Industries Limited's Tramadol shipments, followed by CANADA (26.2%) and SOUTH AFRICA (22.0%). These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Tramadol from SUN Pharmaceutical Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TARO PHARMACEUTICAL USA INC., | UNITED STATES | $660.5K | 15 |
| TARO PHARMACEUTICALS USA INC | UNITED STATES | $613.7K | 14 |
| TARO PHARMACEUTICAL USA INC | UNITED STATES | $600.8K | 17 |
| TARO PHARMACEUTICALS INC., | CANADA | $447.9K | 9 |
| RANBAXY PHARMACEUTICALS (PTY) LTD. | SOUTH AFRICA | $343.8K | 10 |
| TARO PHARMACEUTICALS INC | CANADA | $300.0K | 6 |
| TARO PHARMACEUTICALS INC. | CANADA | $296.1K | 9 |
| RANBAXY PHARMACEUTICALS (PTY) LTD | SOUTH AFRICA | $217.0K | 6 |
| TARO PHARMACEUTICALS USA INC, | UNITED STATES | $149.6K | 5 |
| RANBAXY PHARMACEUTICALS PTY LIMITED | SOUTH AFRICA | $147.2K | 5 |
SUN Pharmaceutical Industries Limited supplies Tramadol to 15 buyers globally. The largest buyer is TARO PHARMACEUTICAL USA INC., (UNITED STATES), followed by TARO PHARMACEUTICALS USA INC (UNITED STATES) and TARO PHARMACEUTICAL USA INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Tramadol Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?
India exported $67.2M worth of Tramadol through 3,928 shipments from 249 suppliers to 103 countries, serving 789 buyers globally. SUN Pharmaceutical Industries Limited contributes $5.1M to this total, accounting for 2.6% of India's Tramadol exports. SUN Pharmaceutical Industries Limited ships Tramadol to 4 countries through 15 buyers.
What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Tramadol Exports?
SUN Pharmaceutical Industries Limited's average Tramadol shipment value is $50.0K per consignment, based on 102 shipments totaling $5.1M. The largest destination is UNITED STATES (51.7% of SUN Pharmaceutical Industries Limited's Tramadol exports).
How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Tramadol Exporters?
SUN Pharmaceutical Industries Limited ranks #7 among 249 Indian Tramadol exporters with a 2.6% market share. The top 3 exporters are RUBICON RESEARCH PRIVATE LIMITED ($11.4M), UNICHEM LABORATORIES LIMITED ($10.3M), MEDREICH LIMITED ($8.2M). SUN Pharmaceutical Industries Limited processed 102 shipments to 4 destination countries.
What Tramadol Formulations Does SUN Pharmaceutical Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| TRAMADOL HYDROCHLORIDE TABLETS USP 50MG | $1.1M | 29 |
| TRAMADOL HCL 50MG 500 TAB PACK : 500sBot | $250.0K | 5 |
| TARO-TRAMADOL HYDROCHLORIDE EXTENDED REL | $250.0K | 5 |
| Tramadol Hydrochloride 100 MG (DOLOTRAMINJ 100MG 2ML 5x1'S AMP ZA) (PACK:SP 05*01) | $179.7K | 5 |
| TARO-TRAMADOL HYDROCHLORIDE EXTENDED RELEASE TABLETS 100 MG [6528 PACKS X 100'SBOTTELS]NOS | $150.0K | 3 |
| TRAMADOL HCL INJECTIONS (DOLOTRAM) 100MG | $102.1K | 3 |
| TARO-TRAMADOL HYDROCHLORIDE EXTENDED RELEASE TABLETS 200MG (TRAMADOL HCL ER 200MG/TABLETS) [2664 PACK X 100'S BOTTLE]NOS | $96.1K | 3 |
| TRAMADOL HCL (DOLOTRAM) 50MG / CAP. (PAC | $91.5K | 3 |
| TRAMADOL HCL INJECTIONS DOLOTRAM 100MG/2ML PACK : 05*01 | $86.7K | 2 |
| TRAMADOL HCL (DOLOTRAM) 50MG / CAPSULE ( | $77.5K | 2 |
SUN Pharmaceutical Industries Limited exports 51 distinct Tramadol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TRAMADOL HYDROCHLORIDE TABLETS USP 50MG with 29 shipments worth $1.1M.
Regulatory Requirements: Exporting Tramadol to Key Markets
What SUN Pharmaceutical Industries Limited must comply with to export Tramadol to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does SUN Pharmaceutical Industries Limited Compare to Nearest Tramadol Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | GRACURE PHARMACEUTICALS LIMITED | $5.6M | 124 | 4 | $44.8K |
| 9 | ZYDUS LIFESCIENCES LIMITED | $5.5M | 208 | 13 | $26.5K |
| 7 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $5.1M | 102 | 4 | $50.0K |
| 10 | INDOCO REMEDIES LIMITED | $4.3M | 87 | 7 | $50.0K |
| 5 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $4.2M | 83 | 1 | $50.0K |
SUN Pharmaceutical Industries Limited ranks #7 among 249 Indian Tramadol exporters. Average shipment value of $50.0K compared to the market average of $270.0K. The closest competitors by value are GRACURE PHARMACEUTICALS LIMITED and ZYDUS LIFESCIENCES LIMITED.
Which Indian Ports Ship Tramadol Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 463 | 11.8% |
| SAHAR AIR | 405 | 10.3% |
| JNPT/ NHAVA SHEVA SEA | 289 | 7.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 264 | 6.7% |
| JNPT | 199 | 5.1% |
| MUNDRA SEA | 150 | 3.8% |
| VIZAG SEA | 108 | 2.7% |
| BANGALORE ICD | 106 | 2.7% |
Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Tramadol Exports
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
About SUN Pharmaceutical Industries Limited
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Tramadol, top products include Strip, Esomeprazole, Magnesium, Calcium, Omeprazole. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tramadol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tramadol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 105 individual customs records matching SUN Pharmaceutical Industries Limited exporting Tramadol, covering 51 formulations to 4 countries via 15 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 103+ countries, 789+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tramadol Export Data from SUN Pharmaceutical Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Tramadol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
Tramadol Stats
Company Overview
Top Products by SUN Pharmaceutical Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tramadol. For current shipment-level data, contact TransData Nexus.